Radiotherapy + Radiopharmaceutical Therapy for Thyroid Cancer

"This medical study is actively recruiting, as indicated on clinicaltrials.gov. It was initially posted back in March 2021 and the information has been updated most recently at the end of October this year."

"Presently, 19 clinical trials concerning this particular treatment are in progress. Of these studies, 4 have reached the third phase of research. Most of the sites conducting this trial can be found in Sevilla and Vizcaya; altogether, 66 different locations are participating."

"Affirmative. According to the clinicaltrials.gov listing, this medical trial is currently in search of participants. It was initially shared on March 17th 2021 and has been updated as recently as October 25th 2022, with a requirement for 48 patients from one site."

"This clinical trial seeks 48 individuals aged 18 or older and not exceeding 85 years of age with a thyroid disorder. In order to be eligible, applicants must satisfy the following conditions: diagnoseable cancer that is not completely removable via surgery yet has infiltrated cervical soft tissues, non-recruitable distant metastases., currently pregnant or breastfeeding, life expectancy 8 weeks minimum, recovery from effects of prior chemotherapy based on organ function as per CTCAE v5.0 grade 2 standards and no previously identified cardiac complications since 131I NaI may cause such issues."

"Taking into account the limited safety and efficacy data, our team's assessment assigns this treatment a score of 1."

"This treatment has proven to be effective in treating communicable diseases, as well as providing antiseptic protection against minor cuts, scrapes or burns and hypothyroidism."

"Adults aged 18-85 are suitable to participate in this research. There are also 34 trials for minors and 232 further studies specifically catering to those over the age of 65."